Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Anish Munagala

Hospitalist Chicago, IL Medical Doctor

NPI 1386135424 CMS profile 5195497

1501 S California Ave, Chicago, IL 60608

Open in the dashboard

General payments

$5,193

138 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Anish Munagala of Chicago, IL is reported in the CMS Open Payments database as having received $5,193 across 138 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Hospitalist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,265 29
2024 General $1,110 26
2023 General $817 30
2022 General $866 30
2021 General $983 19
2020 General $139 3
2019 General $13 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anish Munagala
  • Hospitalist median
  • Middle half of Hospitalist
  • National median

In program year 2025, general payments to Anish Munagala were reported at $1,265. Among 6,882 Hospitalist profiles paid that year, the median was $86 and the middle half received between $30 and $191.

Show as a table
Year Anish Munagala Hospitalist median Middle half National median
2019 $13 $96 $28–$201 $163
2020 $139 $48 $19–$125 $114
2021 $983 $70 $23–$167 $132
2022 $866 $85 $27–$174 $149
2023 $817 $89 $30–$191 $160
2024 $1,110 $95 $29–$204 $164
2025 $1,265 $86 $30–$191 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abiomed $1,080 18 payments
  2. Medtronic, Inc. $775 12 payments
  3. AstraZeneca Pharmaceuticals LP $492 19 payments
  4. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $457 11 payments
  5. Merck Sharp & Dohme Corporation $374 19 payments
  6. Boehringer Ingelheim Pharmaceuticals, Inc. $331 10 payments
  7. Amgen Inc. $301 9 payments
  8. Janssen Pharmaceuticals, Inc $264 8 payments
  9. Abbott Laboratories $208 1 payment
  10. Pfizer Inc. $163 7 payments
  11. Other $747 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,272 131 payments
  2. Education $921 7 payments
Products named General payments · program years 2019–2025
  1. Impella $578 9 payments
  2. LifeVest $457 11 payments
  3. VERQUVO $415 21 payments
  4. FARXIGA $352 9 payments
  5. JARDIANCE $285 8 payments
  6. Repatha $281 8 payments
  7. XARELTO $264 8 payments
  8. ONYX FRONTIER $221 1 payment
  9. EnSite Precision Cardiac Mapping System $208 1 payment
  10. RESOLUTE ONYX $183 1 payment
  11. Other $1,612 61 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

14

Median for Hospitalist: 109

Drug cost

$94

Median for Hospitalist: $6,399

Branded share of claims

0%

Median for Hospitalist: 19.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amlodipine Besylate Generic 14 $94

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,498 Part D prescribers listed as Hospitalist; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 4 billing codes

Paid by Medicare

$1,027

Medicare's payments for the services billed

Medicare patients

16

Average age 75

Services billed

16

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Arthritis 75%
Diabetes 69%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 10 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VYNDAQEL
  • PFIZER INC. $66
$66 — —
XARELTO
  • Janssen Pharmaceuticals, Inc $57
$57 — —
FARXIGA
  • AstraZeneca Pharmaceuticals LP $53
$53 — —
JARDIANCE
  • Boehringer Ingelheim Pharmaceuticals, Inc. $47
$47 — —
VERQUVO
  • Merck Sharp & Dohme Corporation $40
$40 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 10 in the dashboard with a free account

Records

138 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hospitalist in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record